Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: Cancer Cell. 2010 Feb 18;17(3):225–234. doi: 10.1016/j.ccr.2010.01.020

Table 1.

Patient characteristics, metabolite analysis, and IDH status.

Age (yr.) Sex 2HG / glutamate IDH mutation
50 M 0.01 none
54 M n.d. none
55 M n.d. none
57 F 1.94 IDH1 R132G
59 F n.d. none
60 M 0.01 none
61 M 0.11 IDH2 R140Q
62 M 0.47 IDH2 R140Q
65 M n.d. none
66 M 2.98 IDH1 R132C
68 M 0.61 IDH1 R132G
69 M n.d. none
69 F 1.38 IDH1 R132C
69 M 0.46 IDH2 R140Q
70 F 0.66 IDH2 R140Q
71 F n.d. none
72 F 0.32 IDH2 R140Q
78 M 0.01 none